Somai Pharmaceuticals
Somai Pharmaceuticals · page 2
- Companies
Breaking Down Barriers to Medical Cannabis in the UK
UK medical cannabis patients are facing multiple challenges that are preventing the adoption of the legal market.
- Press releases
Somaí Pharmaceuticals Introduces UK To The Most Complete Cannabis-based Product Portfolio Following A Distribution Deal
SOMAÍ Pharmaceuticals Signs Distribution Deal with Grow Pharma for UK’s Most Comprehensive Range of Cannabis-Based Medicines SOMAÍ Pharmaceuticals (“SOMAÍ”), an EU-GMP European pharmaceutical and biotech company distributing cannabinoid-containing pharmaceuticals globally, proudly announces a strategic partnership with Grow Pharma, the UK joint venture of Grow Group PLC and Vertical Pharma Resources Ltd t/a IPS Pharma, dedicated…
- Press releases
Somaí Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position In Medicinal Cannabis Sector
SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”), an EU-GMP European pharmaceutical and biotech company distributing cannabinoid-containing pharmaceuticals globally, today announced it has entered into a definitive agreement with Akanda Corp.
- Opinion
The Global Medical Cannabis Explosion is Imminent
Written by Michael Sassano, CEO, Somai Pharmaceuticals Recently, I have become more optimistic about the global landscape of medical cannabis and the direction in which major regulatory agencies are heading.
- Markets & Stocks
German Cannabis Stocks Spike on CanG Progress, Akanda Offloads Key Sales Generator, & Allied Corp Signs UK Supply Deal
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has seen its share price slip by around 10% this week after it announced plans to sell its Portuguese operations for $2m, seeing it offload a key source of revenue.
- Press releases
Akanda Signs LOI to Sell Portuguese Operations to Somai Pharmaceuticals
Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today announces it has entered into an Amended Non-Binding Letter of Intent (“LOI”)with Somai Pharmaceuticals Ltd. for the sale of RPK, its Portuguese subsidiary.
- Opinion
What’s in Store for the European Cannabis Industry in 2024 – Part 2
2024 is set to be the year of elections, with more than half of the global population (4.2m people) set to vote in over 70 elections around the world.
- Press releases
SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany
SOMAÍ Pharmaceuticals and Canify AG announce their strategic partnership to introduce a differentiated cannabinoid-based product line in Germany SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”), an EU-GMP European pharmaceutical and biotech company distributing cannabinoid-containing pharmaceuticals globally, announces a landmark three-year marketing & distribution agreement with Canify AG (“Canify”), a licensed pharmaceutical company focussing on medical cannabis.
- Press releases
UK’s Largest Medical Cannabis Study Announces New Industry Partners
Drug Science is pleased to welcome three new industry partners to its groundbreaking medical cannabis study, T21 (formerly Project TWENTY21).
- Companies
SOMAÍ Pharmaceuticals Makes ‘Significant Step Towards Revenue Generation’ As Portuguese Market Heats Up
Last month, Portugal’s government announced plans to establish a working group to explore the regulation of adult-use cannabis, with a conclusion expected by the end of the year.
- Cultivation
Albania Officially Green Lights Medical and Industrial Cannabis Cultivation
Albania has become the latest European country to officially legalise the ‘cultivation and processing of the cannabis plant and the production of its by-products for medical and industrial purposes’.
